Monte Rosa Therapeutics, Inc. — 10-Q Filings
14 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Monte Rosa Therapeutics, Inc. (GLUE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Monte Rosa Therapeutics, Inc. has filed 14 10-Q documents with the SEC since 2020. To view all SEC filings by Monte Rosa Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-268045 | Nov 6, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-104550 | Aug 7, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-066372 | May 8, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-122780 | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-093296 | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-056288 | May 9, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-061995 | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-040959 | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-021201 | May 11, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-024447 | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-016844 | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-009324 | May 11, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-004138 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0000950170-21-001372 | Aug 12, 2021 | Jun 30, 2021 |